Antinflammatory, antioxidant, and behavioral effects induced by administration of growth hormone-releasing hormone analogs in mice
Open Access
- 20 January 2020
- journal article
- research article
- Published by Springer Nature in Scientific Reports
- Vol. 10 (1) , 1-14
Abstract
Growth hormone-releasing hormone (GHRH) antagonist MIA-690 and GHRH agonist MR-409, previously synthesized and developed by us have demonstrated potent antitumor effects. However, little is known about the effects of these analogs on brain functions. We investigated the potential antinflammatory and antioxidant effects of GHRH antagonist MIA-690 and GHRH agonist MR-409, on isolated mouse prefrontal cortex specimens treated with lipopolysaccharide (LPS). Additionally, we studied their effects on emotional behavior after chronic in vivo treatment. Ex vivo, MIA-690 and MR-409 inhibited LPS-induced inflammatory and pro-oxidative markers. In vivo, both MIA-690 and MR-409 induced anxiolytic and antidepressant-like effects, increased norepinephrine and serotonin levels and decreased nuclear factor-kB, tumor necrosis factor-α and interleukin-6 gene expression in prefrontal cortex. Increased nuclear factor erythroid 2–related factor 2 expression was also found in mice treated with MIA-690 and MR-409. MIA-690 showed higher efficacy in inhibiting all tested inflammatory and oxidative markers. In addition, MR-409 induced a down regulation of the gene and protein expression of pituitary-type GHRH-receptor in prefrontal cortex of mice after 4 weeks of treatment at 5 µg/day. In conclusion, our results demonstrate anxiolytic and antidepressant-like effects of GHRH analogs that could involve modulatory effects on monoaminergic signaling, inflammatory and oxidative status.Keywords
Funding Information
- Funder: University "G. d'Annunzio" of Chieti Grant Reference Number: FAR 2019
- Funder: University "G. d'Annunzio" of Chieti Grant Reference Number: FAR 2019
This publication has 63 references indexed in Scilit:
- How to calculate sample size in animal studies?Journal of Pharmacology and Pharmacotherapeutics, 2013
- Increased peripheral NF-κB pathway activity in women with childhood abuse-related posttraumatic stress disorderBrain, Behavior, and Immunity, 2012
- A Role for Central Nervous Growth Hormone-Releasing Hormone Signaling in the Consolidation of Declarative MemoriesPLOS ONE, 2011
- Effects of a growth hormone-releasing hormone antagonist on telomerase activity, oxidative stress, longevity, and aging in miceProceedings of the National Academy of Sciences, 2010
- A Meta-Analysis of Cytokines in Major DepressionBiological Psychiatry, 2010
- Inflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major DepressionBiological Psychiatry, 2009
- Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-AnalysisPsychosomatic Medicine, 2009
- Antioxidant activity of growth hormone-releasing hormone antagonists in LNCaP human prostate cancer lineProceedings of the National Academy of Sciences, 2008
- Anxiolytic and antidepressant effects of intracerebroventricularly administered somatostatin: Behavioral and neurophysiological evidenceNeuroscience, 2008
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001